Drug Discovery Solutions

  1. Leveraging Proprietary CDO Platforms

    Explore how a suite of proprietary CDO platforms for BsAbs, transient expression, developability assessment, and more can help optimize every stage of development and accelerate your project timeline.

  2. Scientific Insights Lab Simplifying The Journey From Molecule To Market

    Drug development programs should aid customers in the successful mitigation of technical and regulatory risks to ensure drug products move swiftly through the regulatory approval process and into commercialization. Get service and support to help pharmaceutical and biopharmaceutical manufacturers Simplify the Journey™ from molecule to market.

  3. SUREmAb — Monoclonal Antibody Development, The Way It's Meant To Be 8/4/2023

    Leverage robust development strategies and enable an optimized process for mAb development and manufacturing, efficiency and speed with exceptional quality, and high titers with lower-cost workflows for maximum ROI.

  4. Robust Cell Line Development With Leap-In Transposase® 5/15/2023

    Improve your cell line development and achieve high productivity, rapid timelines, low risk development, and robust genetic stability with an innovative platform.

  5. Discover A Platform For Antibodies With Increased ADCC Activity 5/15/2023

    Explore a platform for antibodies with increased ADCC activity that's compatible with various host cell lines, works across multiple vector configurations, and reduces core fucose within any cell line.

  6. Aragen's Preclinical Oncology Capabilities 3/27/2025

    We provide specialized in vivo pharmacology services, offering customized solutions to support the development of immune-oncology therapies from discovery to commercialization.

  7. Potency Assay Development — Creating Potential Together

    It is necessary to achieve a well-designed and developed potency assay as it is the only analytical technique that can demonstrate the biological mechanism of action and the link to clinical efficacy.

  8. CHEF1™ Expression Technology 2/17/2022

    The platform accelerates development of cell lines for cGMP production by using robust procedures and reliable raw materials, including chemically defined media, adapted Chinese hamster ovary (CHO) cells, and proprietary expression plasmids, to rapidly produce high levels of recombinant protein.

  9. Designed For Inhalation: Pulmonary And Nasal Delivery

    Our newly expanded in-house capabilities span clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays.

  10. Analytical Labs Particle Analysis

    Particulate in a drug product represents a huge risk not only to patient safety – but also to a drug company’s reputation and bottom line. As concern about particulate rises, partnering with a particle analysis team enables customers to gain an intimate understanding of particle sources related to packaging and delivery systems.